1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Uzbekistan Pharmaceuticals and Healthcare Report Q1 2016

Uzbekistan Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 91 pages

Includes 3 FREE quarterly updates

BMI View: Uzbekistan's healthcare system will continue to suffer from human resource constraints,impeding improvements in healthcare outcomes in the long term Drugmakers focused on infectious andcommunicable diseases can expect to see continued revenue growth given the significant burden of diseasessuch as HIV/AIDS, tuberculosis and respiratory diseases, although we expect that this will be moderated bythe low affordability of pharmaceuticals and the limited capacity of the Uzbek healthcare system topurchase medicines for the population

Headline Expenditure Projections

- Pharmaceuticals: UZS221trn (USD956mn) in 2014 to UZS278trn (USD103bn) in 2015; 261% inlocal currency terms and 74% in US dollar terms Forecast unchanged from last quarter
- Healthcare: UZS884trn (USD383bn) in 2014 to UZS1054trn (USD389bn) in 2015; 192% in localcurrency terms and 15% in US dollar terms Forecast unchanged from last quarter

Table Of Contents

Uzbekistan Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Uzbekistan 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Uzbekistan 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Uzbekistan 2011-2019) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Uzbekistan 2013-2019) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Uzbekistan 2013-2019) 32
Industry Risk/Reward Index 33
Central And Eastern Europe Risk/Reward Index - Q1 2016 33
Uzbekistan Risk/Reward Index 40
Rewards 40
Risks 41
Regulatory Review 42
Counterfeit Drugs 43
Intellectual Property Issues 44
Pricing And Reimbursement 45
Market Overview 47
Healthcare Sector 48
Healthcare Provision 50
Health Insurance Sector 51
Healthcare Sector Reforms 52
Research And Development 53
Clinical Trials 54
International Cooperation 54
Epidemiology 56
Competitive Landscape 60
Research-Based Industry 61
Table: Table: Multinational Market Activity 61
Generic Drugmakers 62
Leading Domestic Players 64
Table: List Of Companies In Uzpharmsanoat SJSC (as of October 7 2013) 65
Pharmaceutical Sector Reforms 66
Foreign Pharmaceutical Industry 66
Recent Pharmaceutical Industry Developments 68
Pharmaceutical Wholesale 68
Pharmaceutical Retail 69
Company Profile 70
Jurabek Laboratories 70
Uzpharmsanoat 74
Asklepiy Pharmaceutical Company 78
Demographic Forecast 80
Table: Population Headline Indicators (Uzbekistan 1990-2025) 81
Table: Key Population Ratios (Uzbekistan 1990-2025) 81
Table: Urban/Rural Population and Life Expectancy (Uzbekistan 1990-2025) 82
Table: Population By Age Group (Uzbekistan 1990-2025) 82
Table: Population By Age Group % (Uzbekistan 1990-2025) 83
Glossary 85
Methodology 87
Pharmaceutical Expenditure Forecast Model 87
Healthcare Expenditure Forecast Model 87
Notes On Methodology 88
Risk/Reward Index Methodology 89
Index Overview 90
Table: Pharmaceutical Risk/Reward Index Indicators 90
Indicator Weightings 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.